Evidence map›Paper›PMID 39702460›Full record

Articlenpj aging2024

Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index.

Jacopo Burrello, Jessica Goi, Alessio Burrello, Elena Vacchi, Azucena Rendon-Angel, Edoardo Lazzarini, Giovanni Bianco, Vittorio Limongelli, Giuseppe Vassalli, Carlo W Cereda and 9 more

Abstract read
In one paragraph

Article in npj aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jacopo BurrelloCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Jessica GoiDivision of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.
Alessio BurrelloDepartment of Control and Computer Engineering, Politecnico di Torino, Torino, Italy.
Elena VacchiNeurodegenerative Diseases Group, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.ORCID http://orcid.org/0000-0002-8419-277X
Azucena Rendon-AngelCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Edoardo LazzariniCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Giovanni BiancoNeurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Vittorio LimongelliEuler Institute, Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Lugano, Switzerland.
Giuseppe VassalliFaculty of Biomedical Sciences, Università della Svizzera italiana (USI), Lugano, Switzerland.
Carlo W CeredaFaculty of Biomedical Sciences, Università della Svizzera italiana (USI), Lugano, Switzerland.
Silvia MonticoneDivision of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.
Paolo MulateroDivision of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.
Benedetta BussolatiDepartment of Medical Sciences, University of Torino, Torino, Italy.
Andrea AlimontiFaculty of Biomedical Sciences, Università della Svizzera italiana (USI), Lugano, Switzerland.
Giovanni G CamiciCenter for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
Giorgia MelliNeurodegenerative Diseases Group, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Elena OstoDivision of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
Giovanni PedrazziniFaculty of Biomedical Sciences, Università della Svizzera italiana (USI), Lugano, Switzerland.
Barile LucioCardiovascular Theranostics, Istituto Cardiocentro Ticino, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. lucio.barile@eoc.ch.ORCID http://orcid.org/0000-0002-5827-0439

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) SINERGIA grant number 202302
6 · The paper itself

Abstract

Extracellular vesicles (EVs) offer valuable diagnostic and prognostic insights for cardiovascular (CV) diseases, but the influence of age-related chronic inflammation ("inflammaging") and sex differences on EV profiles linked to CV risk remains unclear. This study aimed to use EV profiling to predict age and stratify patients by CV risk. We developed an EVaging index by analyzing surface antigen profiles of serum EVs from 625 participants, aged 20 to 94 years, across varying CV risk groups. The EVaging index was associated with age in healthy individuals and distinguished CV risk profiles in patients, correlating with CV outcomes and likelihood of fatal CV events according to the European Society of Cardiology (ESC) SCORE, and reflecting age-associated comorbidities. While changes in disease-related EV fingerprint adds complexity in CV patients, EV profiling may help assess biological aging and CV risk, emphasizing EVs' roles in inflammaging.

Identifiers

PMID39702460
PMCPMC11659617

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.